MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

HomeTechnologiesDigital HealthIs Medtech's Pulse Weak or Strong?

Let’s Talk Medtech

Is Medtech's Pulse Weak or Strong?

Jim Welch, EY’s Global MedTech leader, Health Sciences and Wellness division Jim Welch.jpg

EY’s Jim Welch joins MD+DI for a brand-new episode of Let’s Talk Medtech to discuss the findings in the Annual Pulse of the Industry Report.

Omar Ford | Nov 17, 2021

It’s been a trying time for nearly every industry because of the pandemic. However, it seems as if medtech is rising above these challenges.

Deal activity is up, and more companies seem to be going public. EY’s Annual Pulse of the Industry Report shows these trends and touches on the rise of Special Purpose Acquisition Company (SPAC) mergers.

Jim Welch, EY’s Global MedTech leader, Health Sciences and Wellness division, stops by the Let’s Talk Medtech podcast to break down these trends and discuss what they mean for the industry.

Hide comments

Load More

Comments

Plain text